ADAPT Pharma® Welcomes Surgeon General Naloxone Advisory

Apr 5, 2018 PR Newswire

NARCAN® Nasal Spray 4mg is the only FDA-approved, needle-free formulation of naloxone for the emergency treatment of a known or suspected opioid overdoseDUBLIN, April 5, 2018 /PRNewswire/ -- ADAPT Pharma® (Adapt) (www.adaptpharma.com) welcomes the Surgeon General Advisory emphasizing the importance of naloxone.   The Advisory encourages those at increased risk, their friends and family, and other potential witnesses, to be prepared to...